These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19858067)

  • 1. Effects of cytochrome P450 inhibitors on the biotransformation of fluorogenic substrates by adult male rat liver microsomes and cDNA-expressed rat cytochrome P450 isoforms.
    Makaji E; Trambitas CS; Shen P; Holloway AC; Crankshaw DJ
    Toxicol Sci; 2010 Feb; 113(2):293-304. PubMed ID: 19858067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4.
    Stresser DM; Turner SD; Blanchard AP; Miller VP; Crespi CL
    Drug Metab Dispos; 2002 Jul; 30(7):845-52. PubMed ID: 12065444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes.
    Renwick AB; Lavignette G; Worboy PD; Williams B; Surry D; Lewis DF; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2001 Dec; 31(12):861-78. PubMed ID: 11780761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450-mediated hepatic metabolism of new fluorescent substrates in cats and dogs.
    van Beusekom CD; Schipper L; Fink-Gremmels J
    J Vet Pharmacol Ther; 2010 Dec; 33(6):519-27. PubMed ID: 21062303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes.
    Chauret N; Dobbs B; Lackman RL; Bateman K; Nicoll-Griffith DA; Stresser DM; Ackermann JM; Turner SD; Miller VP; Crespi CL
    Drug Metab Dispos; 2001 Sep; 29(9):1196-200. PubMed ID: 11502727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat.
    Kobayashi K; Urashima K; Shimada N; Chiba K
    Drug Metab Dispos; 2003 Jul; 31(7):833-6. PubMed ID: 12814958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes.
    Ghosal A; Hapangama N; Yuan Y; Lu X; Horne D; Patrick JE; Zbaida S
    Biopharm Drug Dispos; 2003 Dec; 24(9):375-84. PubMed ID: 14689466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.
    Cherstniakova SA; Bi D; Fuller DR; Mojsiak JZ; Collins JM; Cantilena LR
    Drug Metab Dispos; 2001 Sep; 29(9):1216-20. PubMed ID: 11502731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of microsomal cytochrome P450-dependent monooxygenases in the rat olfactory mucosa.
    Minn AL; Pelczar H; Denizot C; Martinet M; Heydel JM; Walther B; Minn A; Goudonnet H; Artur Y
    Drug Metab Dispos; 2005 Aug; 33(8):1229-37. PubMed ID: 15879494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cytochrome P450 fluorometric substrates with rainbow trout and killifish exposed to dexamethasone, pregnenolone-16alpha-carbonitrile, rifampicin, and beta-naphthoflavone.
    Smith EM; Wilson JY
    Aquat Toxicol; 2010 May; 97(4):324-33. PubMed ID: 20167382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of enzymes responsible for biotransformation of the new antileukotrienic drug quinlukast in rat liver microsomes and in primary cultures of rat hepatocytes.
    Szotáková B; Skálová L; Baliharová V; Dvorscáková M; Storkánová L; Sispera L; Wsól V
    J Pharm Pharmacol; 2004 Feb; 56(2):205-12. PubMed ID: 15005879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cytochrome P450 2A participating in coumarin 7-hydroxylation in pig liver microsomes.
    Liu ZY; Dai MH; Tao YF; Chen DM; Yuan ZH
    J Vet Pharmacol Ther; 2011 Oct; 34(5):424-9. PubMed ID: 21244437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
    Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J
    Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat.
    Kobayashi K; Urashima K; Shimada N; Chiba K
    Biochem Pharmacol; 2002 Mar; 63(5):889-96. PubMed ID: 11911841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    J Pharmacol Exp Ther; 2001 Apr; 297(1):326-37. PubMed ID: 11259560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coumarin substrates for cytochrome P450 2D6 fluorescence assays.
    Nakamura K; Hanna IH; Cai H; Nishimura Y; Williams KM; Guengerich FP
    Anal Biochem; 2001 May; 292(2):280-6. PubMed ID: 11355862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
    Grubb MF; Diamond S; Christ DD
    Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
    Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ
    Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes.
    Ono S; Hatanaka T; Hotta H; Satoh T; Gonzalez FJ; Tsutsui M
    Xenobiotica; 1996 Jul; 26(7):681-93. PubMed ID: 8819299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.